Future of Food: Have plant-based protein sales peaked?
UBS Evidence Lab data shows taste improvement remains the key catalyst for broader adoption. Corporate engagement with the category remains high.
header.search.error
UBS All China Equity Fund
Please read the important information of the fund before proceeding
UBS (Lux) Equity SICAV – All China (USD)
1. The Fund, UBS (Lux) Equity SICAV – All China (USD) (" UBS All China Equity Fund"), invests mainly in shares and other equity interests of companies domiciled in the People’s Republic of China (“PRC”) as well as in other companies that have close economic links with the PRC. These investments contain securities listed within the PRC (onshore) or outside of the PRC (offshore).
Bringing you the best of China equity markets
China's onshore stock markets have opened up and now the distinction between offshore and onshore markets is increasingly irrelevant. Our goal is to fully capture the best opportunities in onshore and offshore markets, that will be benefited from China's long-term growth.
Fund features
An “All China equity” approach allows investors to tap into the best opportunities that the China onshore and offshore markets can offer.
Number of IPOs
In our research, onshore markets have more companies in fast-growing healthcare and consumer sectors, while offshore markets have a big selection of innovative tech and services companies.
Bin Shi, Head of China Equities
More funds
UBS Evidence Lab data shows taste improvement remains the key catalyst for broader adoption. Corporate engagement with the category remains high.
Consumer goods brands in the 'branded' stage might provide more value.
Asian inflation was remarkably benign in 2021 but price pressures rose in the first half of 2022. Will ASEAN inflation take off as it did in the Americas and Europe or are different dynamics at work?
Meet the members of the team responsible for UBS Asset Management’s strategic direction.